INC Research/inVentiv now Syneos Health

04-Jan-2018 - Last updated on 04-Jan-2018 at 21:10 GMT

(Image: iStock/manaemedia)

INC Research/inVentiv Health is starting the new year with a rebrand after merging to create one of the largest biopharmaceutical outsourcing providers in 2017.

The company, with a combined staff of more than 21,000 employees across more than 60 counties, will now be known as Syneos Health, Inc., effective January 4, 2018.

Syneos Health common shares will trade on the Nasdaq Global Select Market under the new ticker symbol “SYNH” by January 9, 2018.

"Since close, we’ve quickly assembled an Integrated Solutions Group, bringing together seasoned industry product strategists with regulatory, clinical, commercial and real world expertise," Alistair Macdonald, CEO of Syneos Health told Outsourcing-Pharma.com.

"This group is working with customers across the small to mid to large continuum to determine the right mix of clinical and commercial capabilities to produce a higher likelihood of launch success,” he added.

Also this week, the company announced that Greg Rush is stepping down as chief financial officer (CFO) to pursue a different opportunity. The company has initiated the search for a replacement.

The current executive vice president and CFO of the company’s commercial solutions business will be appointed as interim CFO at the end of April if a replacement has not been found, according to the company.